compounding semaglutide fda enforcement news today pharmacies to halt sales May 22 Compounded Semaglutide: FDA 2026 Rule

Food and Drug Administration (FDA) approvals for weight management and, more recently, cardiovascular disease prevention

Thermogenic ingredients and body weight regulation

However, once opened, the vial should be used within 28 days to maintain safety and efficacy, after which it should be discarded

Certificate of Analysis (COA) [Instant Verification via QR Code]

GLP-1 microdosing is the medical practice of administering very small doses of a drug, often to provide dose-specific benefits that might be different than the regular dose, while minimizing side effects

KB has received funding from the Rosetrees Trust and Stoneygate Trust and National Institute for Health and Care Research (NIHR)